The central melanocortin system is critical in the regulation of appetite and body weight, and leptin exerts its anorexigenic actions partly by increasing hypothalamic proopiomelanocortin (POMC) expression. The POMC-derived peptide ␣-melanocytestimulating hormone (␣MSH) is a melanocortin 4 receptor agonist, and its potency in reducing energy intake is strongly increased by N-acetylation. The reason for the higher biological activity of N-acetylated ␣MSH (Act-␣MSH) compared with that of N-desacetylated ␣MSH (Des-␣MSH) is unclear, and regulation of acetylation by leptin has not been investigated. We show here that total hypothalamic ␣MSH levels are decreased in leptin-deficient ob͞ob mice and increased in leptin-treated ob͞ob and C57BL͞6J mice. The increase in total ␣MSH occurred as soon as 3 h after leptin injection and was entirely due to an increase in Act-␣MSH. Consistent with this observation, leptin rapidly induced the enzymatic activity of a N-acetyltransferase in the hypothalamus of mice. In 293T cells expressing the melanocortin 4 receptor, Act-␣MSH is far more potent than Des-␣MSH in stimulating cAMP accumulation, an effect caused by a dramatically increased stability of Act-␣MSH. Moreover, Des-␣MSH is rapidly degraded in the hypothalamus after intracerebroventricular injection in rats and was less potent in inhibiting energy intake. The results suggest that leptin activates a N-acetyltransferase in POMC neurons, leading to increased hypothalamic levels of Act-␣MSH. Due to its increased stability, this posttranslational modification of ␣MSH may play a critical role in leptin action via the central melanocortin pathway.
T
he adipocyte-derived hormone leptin is expressed in fat tissue and acts on the central nervous system to inform key regulatory centers about energy stores (1) (2) (3) . Leptin receptors (ObRs) are highly expressed within the hypothalamus, including in proopiomelanocortin (POMC) neurons located in the arcuate nucleus (4, 5) . POMC-derived neuropeptides, primarily ␣-melanocyte-stimulating hormone (␣MSH), activate the melanocortin 4 receptor (MC4R) and function downstream of leptin signaling to regulate energy balance, although other pathways are also important (6) (7) (8) (9) (10) . Supporting the role of the melanocortin pathway in leptin action are data showing that central injection of synthetic melanocortin receptor antagonists inhibits the effect of leptin to reduce food intake (10) . Furthermore, mutations in the pomc and mc4r genes result in severe obesity in mice (6, 11) and humans (7, 12) .
Studies investigating the regulation of POMC neurons by leptin have focused mainly on gene expression analyses. It is known that fasting, which is a state of low serum leptin levels, results in reduced amounts of POMC mRNA levels. This reduction is also seen in the hypothalamus of the leptin-deficient ob͞ob mice (13) (14) (15) (16) . In addition, hypothalamic POMC mRNA is stimulated by the administration of recombinant leptin to rodents (16) . However, few studies have examined regulation of hypothalamic POMC-derived peptides, such as ␣MSH, in response to leptin. Generation of ␣MSH from POMC involves extensive posttranslational processing by prohormone convertases 1 and 2 (PC1 and PC2) and carboxypeptidase E (CPE) and amidation on the C terminus by peptidyl ␣-amidating monooxygenase (PAM) (17) . Moreover, mature ␣MSH [N-acetylated ␣MSH (Act-␣MSH)] is generated from desacetylated ␣MSH (Des-␣MSH) by a N-acetyltransferase that has yet to be identified (17) . The amount of Act-␣MSH in the rodent brain is controversial, because some studies report undetectable levels of the N-acetylated form in the hypothalamus (18) (19) (20) . On the other hand, it is well established that synthetic Act-␣MSH is far more potent than Des-␣MSH in reducing food intake when administered centrally in rats (21, 22) . It is presently unclear whether N-acetylation of hypothalamic ␣MSH is regulated by leptin, and the mechanism underlying the different potencies of the two forms of ␣MSH is poorly understood.
The purpose of this study was therefore fourfold: (i) to determine total ␣MSH levels in hypothalamic extracts in response to leptin, (ii) to investigate the potential role of leptin to influence N-acetylation of ␣MSH, (iii) to determine whether leptin can regulate hypothalamic ␣MSH N-acetyltransferase activity, and (iv) to understand the mechanism by which Act-␣MSH is more potent than Des-␣MSH in activating MC4R signaling and inhibiting feeding.
Materials and Methods
Animals. Male Wistar rats and C57BL͞6J mice were purchased from Charles River Laboratories. Leptin-deficient ob͞ob mice and WT littermates on the C57BL͞6J background were purchased from The Jackson Laboratory. Animals were individually housed and maintained at 25°C with a 14-h͞10-h light͞dark cycle. Animal procedures were performed in accordance with the guidelines and approval of the Harvard Medical School and Beth Israel Deaconess Medical Center institutional animal care and use committees.
from Bachem was iodinated with 125 I, purified by HPLC, and used as tracer. The RIA was performed in a volume of 0.5 ml of PBS (pH 7.4)͞500 mg/liter sodium azide͞2.5 g/liter BSA (SigmaAldrich) by using the anti-␣MSH serum (1:10,000) and 5,000 cpm of 125 I-␣MSH tracer.
Separation of Hypothalamic Act-␣MSH and Des-␣MSH by HPLC.
␣MSH peptides were separated by HPLC analysis using a Symmetry C18 (5 m) column (4.6 ϫ 150 mm) (Waters). The mobile phase consisted of a gradient between 0.1% trifluoroacetic acid in water and acetonitrile͞methanol (80:20). The flow rate was 1 ml͞min, and 1-ml fractions were collected and concentrated by a SpeedVac system (Appropriate Technical Resources, Laurel, MD).
Immunohistochemistry. ␣MSH peptides were detected in rat brain sections by immunohistochemistry as described previously (23) .
Leptin Treatments in Mice for Measurement of Hypothalamic ␣MSH.
Recombinant murine leptin was from A. F. Parlow (National Hormone and Pituitary Program, Torrance, CA). One experiment involved three groups of C57BL͞6J mice that were individually housed. One group was treated for 3 days with two daily i.p. injections of leptin (50 g per injection) and fed ad libitum. The second group (control) was injected with PBS and fed ad libitum. The third group (pair-fed) was injected with PBS and pair-fed to the leptin-treatment group. Pair-feeding was done by measuring the food intake of the ad libitum-fed leptin-treated mice every 24 h. The following day, the PBS-treated pair-fed mice were given the average amount of food consumed by the leptin-treated mice on the previous day. In a separate experiment, ob͞ob mice and control littermates were injected i.p. with 100 g of leptin or PBS and killed 3 h after injection. Food was removed during the latter experiment.
Cell Culture, Transient Transfection, and DNA Constructs. HEK 293T cells were grown in DMEM with 10% FCS, penicillin (100 units͞ml), and streptomycin (100 g͞ml) at 37°C in 5% CO 2 . Reagents for tissue culture were from Invitrogen Life Technologies. Cells were transfected by using Lipofectamine and OPTI-MEM medium (Invitrogen), and treatments were done Ϸ18 h posttransfection. The MC4R expression vector and CREluciferase reporter construct were kindly provided by J. S. Flier and A. N. Hollenberg (Beth Israel Deaconess Medical Center). The CMV-lacZ reporter construct was from Clontech.
Luciferase and ␤-Galactosidase Assays. Luciferase and ␤-galactosidase activities were measured as described in ref. 24 .
Measurement of Intracellular cAMP. HEK 293T cells were transfected as described above. In some experiments, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX, Sigma-Aldrich) was added 30 min before the addition of peptides. Cellular cAMP was measured according to the manufacturer's instructions (RPN 225, Amersham Pharmacia).
Determination of ␣MSH Peptide Stability. Fifty nanomolar Des-␣MSH or Act-␣MSH was incubated in 0.5 ml of medium with or without cells for different periods of time, and the residual amount of peptides was measured by RIA. For degradation studies in brain lysates, 50 nM Des-␣MSH or Act-␣MSH was incubated in 0.4 ml of fresh mouse brain lysates at 37°C. The reaction was terminated by the addition of 0.4 ml of 0.2 M HCl and residual peptides determined by RIA. The brain lysate was generated by homogenizing the brain from one C57BL͞6J mouse in 2.5 ml of PBS buffer. The final clarified lysate was obtained by centrifugation of the homogenate and dilution of the supernatant to a protein concentration of 1 mg͞ml in PBS buffer. Intracerebroventricular Injections. Permanent 22-gauge cannulae were preimplanted into the third ventricle of male Wistar rats by Charles River Laboratories. For measurement of 2-h food intake, saline or 3 nmol of Des-␣MSH or Act-␣MSH (5 l each) was administered into the third ventricle before the onset of the dark segment of the light͞dark cycle. Food was removed 6 h before injection and returned after injection. For peptide degradation analyses, residual amounts of Des-␣MSH and Act-␣MSH in hypothalamic extracts were measured by RIA after intracerebroventricular administration. The injection rate was 1 l͞min in all experiments.
Measurement of ␣MSH N-Acetyltransferase Enzyme Activity. Hypothalamic explants from leptin-injected (i.p., 100 g, 3 h) or PBS-injected C57BL͞6J or ob͞ob mice were homogenized in a 50 mM Tris⅐HCl buffer (pH 7.4) containing 50 mM KCl, 3 mM MgCl 2 , and 300 mM sucrose in a total volume of 200 l. The homogenate was centrifuged, and 10 l of the supernatant was incubated with 10 l of 60-pmol Des-␣MSH and 2.5 l of 30 M acetyl CoA for 10 min at 37°C. The reaction was terminated by the addition of 25 l of 2 M acetic acid. Samples were injected into the HPLC system, and fractions were analyzed by RIA.
Results

Hypothalamic Content of ␣MSH Peptides in C57BL͞6J Mice and Wistar
Rats. To examine posttranslational modification and regulation of hypothalamic ␣MSH in rodents, we first developed an RIA. The assay was equally sensitive in detecting purified peptides of Des-␣MSH and Act-␣MSH, and the sensitivity was 5 fmol per sample. To further test the specificity of the assay on biological samples, levels of total ␣MSH were determined in tissues known to contain high or low levels. We found 0.75 Ϯ 0.2 pmol per hypothalamus in C57BL͞6J mice and 1.8 Ϯ 0.2 pmol per hypothalamus in Wistar rats. ␣MSH was not detected in the cortex (Fig. 1A ). This observation is consistent with immunohistochemical analyses of brain sections from rats using a different ␣MSH antibody than that used in the RIA, showing the expected presence of ␣MSH-producing (POMC) neurons in the hypothalamus, but no staining in the cortex ( Fig. 1 A Insets) . The hypothalamic levels of total ␣MSH are consistent with previous reports (19, 20) .
Total Hypothalamic ␣MSH Levels Are Reduced in ob͞ob Mice and
Elevated by Leptin Treatment. To examine regulation of total hypothalamic ␣MSH by leptin, hypothalami were isolated from leptin-deficient ob͞ob mice and from leptin-treated mice. In ob͞ob mice, ␣MSH levels were decreased by Ϸ35%, compared with those in WT littermates, and a single injection of leptin increased the amounts 3 h after administration (Fig. 1B) . Leptin also increased steady-state levels of hypothalamic ␣MSH in C57BL͞6J mice after 3 days of leptin treatment, compared with those in control and pair-fed mice (Fig. 1C) . These results show that leptin can positively regulate total hypothalamic ␣MSH levels in mice, consistent with data showing that leptin can increase hypothalamic POMC mRNA (13, 16, 25) .
Leptin Stimulates N-Acetylation of ␣MSH in the Hypothalamus. To measure N-acetylation of ␣MSH, we developed conditions to separate Des-␣MSH and Act-␣MSH by HPLC. The retention times of Des-␣MSH and Act-␣MSH were obtained by loading 6 nmol of Des-␣MSH and Act-␣MSH standards on the HPLC system followed by UV detection (OD 220 ). As shown in Fig. 2A , the two peptides separated as individual peaks with Des-␣MSH eluting at 36 min and Act-␣MSH at 47 min. Because hypothalamic ␣MSH levels in mice are much lower (Ϸ1 pmol; see Fig.  1 ), we also demonstrated that 0.15 pmol of the peptide standards could be detected in the expected fractions by HPLC followed by RIA (data not shown). Analysis of hypothalamic extracts showed Ϸ0.15 pmol of Act-␣MSH and Ϸ0.58 pmol of Des-␣MSH in fed C57BL͞6J mice, and Ϸ0.35 pmol of Act-␣MSH and Ϸ1.32 pmol of Des-␣MSH in fed rats. This result demonstrates that both Des-␣MSH and Act-␣MSH exist in the hypothalamus of rats and mice and that Des-␣MSH is the predominant form (Ϸ80%). Earlier studies have reported presence of diacetyl-␣MSH in the rat hypothalamus, although the levels were extremely low (19) . Our data show that the identified acetylated MSH in the hypothalamus is monoacetylated, because the retention time of endogenous hypothalamic Act-␣MSH is identical to that of the synthetic mono-N-acetylated peptide.
Hypothalamic extracts from leptin-treated C57BL͞6J mice and PBS-injected control and pair-fed groups were next analyzed by HPLC coupled with RIA; representative elution profiles are shown in Fig. 2B . Three days of leptin treatment of C57BL͞6J mice caused an Ϸ300% increase in Act-␣MSH, compared with that in control and pair-fed groups, whereas there was no significant change in steady-state levels of Des-␣MSH (Fig. 2C) . The amounts of Act-␣MSH and Des-␣MSH were both decreased in the hypothalamus of ob͞ob mice, compared with those in the hypothalamus of WT littermates (Fig. 2D) . Three hours after leptin administration, the levels of Act-␣MSH, but not Des-␣MSH, were significantly increased in ob͞ob mice. These data show that recombinant leptin can specifically increase the hypothalamic content of Act-␣MSH in C57BL͞6J and ob͞ob mice.
Leptin Rapidly Stimulates the Activity of an ␣MSH N-Acetyltransferase in the Hypothalamus. The rapid and specific increase of Act-␣MSH after leptin administration suggests activation of an ␣MSH N-acetyltransferase in the hypothalamus. To examine this possibility, we injected C57BL͞6J mice with either leptin or vehicle. Three hours later, hypothalamic protein extracts were obtained and mixed with purified Des-␣MSH peptides and acetyl CoA for 10 min at 37°C and subjected to HPLC and RIA. As shown in Fig. 3A , little Act-␣MSH was generated in hypothalamic extracts from vehicle-treated mice. In contrast, leptin injection resulted in a dramatic increase in formation of Act-␣MSH in the assay. Similar results were obtained from analysis of leptin-treated ob͞ob mice (Fig. 3B ). These data demonstrate that leptin can rapidly stimulate the activity of a hypothalamic Significant differences were determined by Student's t test. ** , P Ͻ 0.05; *** , P Ͻ 0.0005. N-acetyltransferase with the capacity to acetylate ␣MSH at the N terminus.
Act-␣MSH Is More Potent than Des-␣MSH in Reducing Food Intake in
Rats and in Activating MC4R Signaling in Transfected Cells. To investigate the different potencies of the two forms of ␣MSH (26), we first measured food intake after intracerebroventricular injection of purified peptides into rats. As shown in Fig. 4A , Act-␣MSH caused an Ϸ30% decrease in 2-h energy intake, whereas Des-␣MSH was without effect, confirming earlier data (21) . To examine the mechanism underlying this difference, the bioactivity of Act-␣MSH and Des-␣MSH was studied in a transfection system. Because Des-␣MSH and Act-␣MSH mediate their central effects through the melanocortin G proteincoupled receptors (27), we generated a heterologous cell system consisting of 293T cells transfected with MC4R plasmids and a cAMP-responsive luciferase reporter construct. Cells were stimulated with different doses of Des-␣MSH or Act-␣MSH for 5 h, and luciferase activities were measured. We found that Act-␣MSH was far more potent than Des-␣MSH in activating MC4R signaling (Fig. 4B) , a finding thus consistent with the differential in vivo effects on food intake. EC 50 values of Des-␣MSH and Act-␣MSH were 316 and 1.1 nM, respectively.
It has been reported that Act-␣MSH and Des-␣MSH bind to the MC4R with similar affinities (21) and that the peptides have equal capacity to activate intracellular signaling as measured by cAMP assays (21, 28) . To understand the reason for the apparent discrepancies between these published results (21, 28) and the above data, we first examined cAMP activation by Des-␣MSH and Act-␣MSH. Dose responses and time courses of intracellular cAMP accumulation after stimulation of 293T cells expressing MC4R are shown in Fig. 5 . In the presence of IBMX, a commonly used inhibitor of cellular phosphodiesterases, Act-␣MSH and Des-␣MSH dose-dependently stimulated cAMP production with similar potencies (Fig. 5A ) and time courses (Fig. 5B) . In contrast, in the absence of IBMX pretreatment, the dose responses diverged between the peptides, showing that Act-␣MSH was more potent in stimulating intracellular cAMP (Fig. 5C ). This difference was more pronounced when examined further at a submaximum concentration (Fig. 5D) . We conclude that IBMX pretreatment, which results in Ϸ10-fold higher cAMP responses, is masking signaling differences between the peptides, which may explain why earlier studies in which IBMX pretreatment was used (21, 28) did not detect increased activity of Act-␣MSH. Therefore, our cAMP signaling data are consistent with the transcriptional signaling results and altogether demonstrate that Act-␣MSH is more potent than Des-␣MSH both in vitro and in vivo.
Act-␣MSH Is More Stable than Des-␣MSH in a Cell
System and in the Rodent Brain. To examine whether peptide stability might explain the differential activity of the two peptides, 50 nM of each peptide was incubated in the medium with 293T cells for different periods of time. As shown in Fig. 6A , Ϸ75% of Act-␣MSH remained in the medium after 5 h of incubation. In striking contrast, Des-␣MSH disappeared to undetectable levels. Both peptides were equally stable after 5 h in pure medium (Fig.  6B, black bars) , but Des-␣MSH was fully degraded in the presence of cells (Fig. 6B, gray bar) , demonstrating a role of a cell-derived factor. Moreover, the disappearance of Des-␣MSH and partial degradation of Act-␣MSH occurred independently of expression of the MC4R (Fig. 6B, white bar) . Combined, the data suggest that the decreased potency of Des-␣MSH in activating MC4R signaling is due to rapid degradation of the peptide, resulting in loss of its biological activity.
To further support these results, we tested the stability of the two peptides in brain lysates from C57BL͞6J mice and after central injection into cannulated rats. As shown in Fig. 6C , Act-␣MSH was more stable than Des-␣MSH when incubated with mouse brain lysates. After 20 min, Ϸ80% of Act-␣MSH remained, whereas Des-␣MSH was undetectable. Moreover, when 3 nmol of Des-␣MSH and Act-␣MSH was administered into the third ventricle of rats, Des-␣MSH was degraded to basal levels 30 min postinjection, whereas significant amounts of Act-␣MSH remained in the hypothalamic extract (Fig. 6D, black  bars) . Similar results were observed with 10 times less peptide (Fig. 6D, white bars) . We conclude that the higher potency of Act-␣MSH in activating MC4R signaling in transfected cells and in inhibiting feeding in rats is due to a dramatically increased stability of the peptide. The data suggest that central proteases͞ peptidases may exist with relative higher specificity toward the nonacetylated form of ␣MSH. Fig. 3 . Leptin stimulates the activity of an ␣MSH N-acetyltransferase in the hypothalamus of C57BL͞6J and ob͞ob mice. Hypothalamic protein extracts from mice injected with either leptin or PBS (3 h) were incubated with purified Des-␣MSH and acetyl CoA for 10 min. Samples were applied to an HPLC system, and fractions were measured by RIA. The condition of the HPLC analysis was changed so that elution times were different, compared with those shown in 
Discussion
Our data demonstrate that leptin specifically and rapidly stimulates generation of Act-␣MSH in the hypothalamus of mice. This is likely caused by a leptin-dependent increase in the activity of a N-acetyltransferase in the hypothalamus, presumably in POMC neurons. We also show that the N-acetylated form of the peptide is more potent in activating MC4R signaling and in reducing food intake, effects that are likely due to rapid degradation of the nonacetylated form of ␣MSH. Combined, these data suggest that increased N-acetylation of ␣MSH is a critical step in the central leptin-melanocortin pathway to inhibit appetite and body weight.
We also show that hypothalamic levels of total ␣MSH peptides are regulated by leptin. Specifically, the chronic lack of leptin in ob͞ob mice leads to a decrease in ␣MSH, and leptin treatment rapidly increases the hypothalamic content. These results are clearly consistent with studies showing low levels of hypothalamic POMC mRNA in ob͞ob mice and in food-deprived animals and that leptin can stimulate POMC gene expression (13, 16, 25) . The generation of mature ␣MSH from POMC requires a complex pathway of posttranslational modifications involving numerous enzymes such as PC1 and PC2. Interestingly, Renz et al. (29) have suggested that leptin may regulate PC2 expression in the pituitary, raising the possibility that this regulation may also occur in POMC neurons. We therefore cannot rule out that the increase in total ␣MSH in response to leptin is a result of both a stimulatory effect on pomc gene expression (13, 16, 25) and enhanced posttranslational processing of the POMC precursor.
The mechanism whereby leptin specifically enhances steadystate levels of Act-␣MSH without significantly affecting hypothalamic amounts of Des-␣MSH remains unclear. An intriguing possibility that may account for this selectivity is that leptin acts on only a subpopulation of POMC neurons, consistent with our earlier data showing that leptin activates Ϸ40% of POMC neurons (23) . We therefore hypothesize that leptin may coordinately stimulate POMC expression and activate the ␣MSH N-acetylating enzyme in this subpopulation of POMC neurons without affecting the amounts or acetylation of ␣MSH in POMC cells that do not express the leptin receptor. We also show that both forms of ␣MSH are significantly decreased in hypothalamus of leptin-deficient ob͞ob mice. The fact that only Act-␣MSH is increased in leptin-treated ob͞ob mice may suggest that factors other than leptin regulate the content of Des-␣MSH in these mice. More specifically, it is possible that the lack of leptin in ob͞ob mice may reduce the amount of Act-␣MSH in leptinresponsive POMC neurons, whereas other factors that are altered in ob͞ob mice may specifically reduce levels of Des-␣MSH in non-leptin-responsive cells. Further anatomical or genetic studies are required to test these hypotheses.
It has been suggested that the N-acetyltransferase responsible for N-acetylation of ␣MSH in the pituitary is expressed in secretory vesicles near the cell membrane (30) . Analysis of ␣MSH peptides in rat hypothalami ex vivo shows that the majority (Ͼ90%) of ␣MSH released under basal conditions is the nonacetylated form (20) . Interestingly, treatment of these hypothalamic explants with the secretagogue KCl resulted in a 3-to 4-fold higher proportion of Act-␣MSH in the medium. Because it has been shown that leptin rapidly depolarizes POMC neurons (31) , leading to the release of ␣MSH (32), one possibility is that N-acetylation of ␣MSH occurs in association with the release process. Determination of the relative levels of the two forms of ␣MSH released from nerve terminals of leptinresponsive POMC neurons and elucidation of how leptin regulates N-acetyltransferase activity remain open questions.
The mechanism explaining the higher biological potency of Act-␣MSH has remained elusive. We applied a heterologous transfection system to study the activity of the two forms of ␣MSH under well defined conditions. We found that Act-␣MSH is far more potent than Des-␣MSH in activating MC4R-dependent transcriptional activation of a cAMP-inducible reporter gene. Consistent with this finding, in the absence of IBMX, Act-␣MSH is more active than Des-␣MSH in stimulating intracellular levels of cAMP. This indicates that measurement of cAMP after pretreatment of cells with IBMX does not truly reflect melanocortin receptor signaling and may explain why differences in potencies were not detected in earlier studies (21) . Furthermore, Des-␣MSH is rapidly subjected to degradation in a mammalian cell line. Although it was reported that MC4R undergoes ␣MSH-dependent internalization (33) , our data show that the disappearance of ␣MSH occurs independently of the MC4R. Des-␣MSH was also rapidly degraded in brain lysates from mice and after central injection in rats. Combined, these data suggest that the increased biological activity of Act-␣MSH in inhibiting feeding is due to rapid proteolysis of the nonacetylated form of the peptide and that acetylation of ␣MSH may serve to protect the peptide against enzymatic degradation.
In conclusion, our data suggest that central leptin action via the melanocortin pathway to affect energy balance has additional levels of complexity, namely regulation of N-acetylation of ␣MSH and enzymatic degradation of ␣MSH peptides. The identities of the enzymes responsible for these processes are unknown. Cloning of the genes and examination of their potential regulation requires further studies that may provide identification of novel antiobesity drug targets. Finally, it is possible that mutations in the genes encoding these enzymes may explain some cases of human obesity.
